{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:54:16Z","timestamp":1778324056155,"version":"3.51.4"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jsbmb.2025.106900","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:30:24Z","timestamp":1763631024000},"page":"106900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Context-dependent effects of progesterone 4-pregnene metabolites on apoptosis and proliferation in ovarian cancer cell lines IGROV-1 and SK-OV-3"],"prefix":"10.1016","volume":"256","author":[{"given":"M.A.","family":"Sanhueza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.T.","family":"Pelegrina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.R.","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Cardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roig Cerde\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Iba\u00f1ez Cannav\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"Bruna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.D.","family":"Cuello-Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Laconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106900_bib2","article-title":"Aetiology, Epidemiology, Histopathology, Classification, Detailed Evaluation, and Treatment of Ovarian Cancer","volume":"14","author":"Zamwar","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106900_bib3","doi-asserted-by":"crossref","first-page":"dju249","DOI":"10.1093\/jnci\/dju249","article-title":"Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer","volume":"106","author":"Konecny","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2025.106900_bib4","article-title":"A review focusing on carcinoma and recent advances","author":"Sciallis","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"FIGO Committee for Gynecologic Oncology. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J. Gynaecol. Obstet."},{"key":"10.1016\/j.jsbmb.2025.106900_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"IeM. Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Annu Rev. Pathol."},{"issue":"4-6","key":"10.1016\/j.jsbmb.2025.106900_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000086967","article-title":"Current concepts of treatment strategies in advanced or recurrent ovarian cancer","volume":"68","author":"Salzberg","year":"2005","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106900_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00404-017-4484-8","article-title":"Palliative care in ovarian carcinoma patients\u2014a personalized approach of a team work: a review","volume":"296","author":"Segev","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106900_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/jcb.21304","article-title":"Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression","volume":"102","author":"Syed","year":"2007","journal-title":"J. Cell Biochem"},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106900_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/09513590.2010.538100","article-title":"Progesterone inhibits growth and induces apoptosis in cancer cells through modulation of reactive oxygen species","volume":"27","author":"Nguyen","year":"2011","journal-title":"Gynecol. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106900_bib11","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.3892\/or.2013.2680","article-title":"Progesterone protects ovarian cancer cells from cisplatin-induced inhibitory effects through progesterone receptor membrane component 1\/2 as well as AKT signaling","volume":"30","author":"Zhu","year":"2013","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106900_bib12","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1210\/en.2009-0730","article-title":"Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice","volume":"150","author":"Peluso","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2025.106900_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108680","article-title":"Progesterone decreases ovarian cancer cells migration and invasion","volume":"161","author":"Lima","year":"2020","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2025.106900_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.02.005","article-title":"Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development","volume":"158","author":"Jeon","year":"2016","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106900_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study","volume":"14","author":"Sieh","year":"2013","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13048-019-0486-4","article-title":"Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer","volume":"12","author":"Pedernera","year":"2019","journal-title":"J. Ovarian Res"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106900_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ygyno.2004.11.010","article-title":"Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer","volume":"96","author":"Lee","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106900_bib18","first-page":"1051","article-title":"Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study","volume":"18","author":"Hogdall","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jsbmb.2025.106900_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/1471-2407-12-553","article-title":"Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival","volume":"12","author":"Lenhard","year":"2012","journal-title":"BMC Cancer"},{"issue":"22","key":"10.1016\/j.jsbmb.2025.106900_bib20","doi-asserted-by":"crossref","first-page":"36845","DOI":"10.18632\/oncotarget.15982","article-title":"Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis","volume":"8","author":"Luo","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106900_bib21","first-page":"1075","article-title":"Menopausal hormone therapy and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition","volume":"22","author":"Tsilidis","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106900_bib22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/bjc.2012.397","article-title":"Ovarian cancer and menopausal hormone therapy in the NIH-AARP Diet and Health Study","volume":"107","author":"Trabert","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"9980","key":"10.1016\/j.jsbmb.2025.106900_bib23","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Beral","year":"2015","journal-title":"Lancet"},{"issue":"50","key":"10.1016\/j.jsbmb.2025.106900_bib24","doi-asserted-by":"crossref","first-page":"31993","DOI":"10.1073\/pnas.2013595117","article-title":"Targeting progesterone signaling prevents metastatic ovarian cancer","volume":"117","author":"Kim","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S0022029905001214","article-title":"Role of progesterone metabolites in mammary cancer","volume":"72","author":"Wiebe","year":"2005","journal-title":"J. Dairy Res"},{"issue":"1-2","key":"10.1016\/j.jsbmb.2025.106900_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2003.11.006","article-title":"Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins","volume":"215","author":"Penning","year":"2004","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106900_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2017.00119","article-title":"Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy","volume":"8","author":"Zeng","year":"2017","journal-title":"Front Pharm."},{"issue":"1-3","key":"10.1016\/j.jsbmb.2025.106900_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cbi.2012.10.028","article-title":"Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line","volume":"202","author":"Berani\u010d","year":"2013","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106900_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cbi.2014.09.024","article-title":"The aldo-keto reductases (AKRs): Overview","volume":"234","author":"Penning","year":"2015","journal-title":"Chem. Biol. Inter."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106900_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and Functional Biology of Aldo-Keto Reductase Steroid-Transforming Enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2025.106900_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106113","article-title":"Porcine aldo-keto reductase 1C subfamily members AKR1C1 and AKR1C4: Substrate specificity, inhibitor sensitivity and activators","volume":"221","author":"Endo","year":"2022","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106900_bib32","article-title":"Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): Functions, regulation, and structural insights of inhibitors","author":"Chu","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"1-3","key":"10.1016\/j.jsbmb.2025.106900_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cbi.2012.11.012","article-title":"Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer","volume":"202","author":"Sinreih","year":"2013","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106900_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cbi.2014.11.012","article-title":"Important roles of the AKR1C2 and SRD5A1 enzymes in progesterone metabolism in endometrial cancer model cell lines","volume":"234","author":"Sinreih","year":"2015","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106900_bib35","doi-asserted-by":"crossref","unstructured":"Wiebe, J., Jarvis, J., & Kwok, A. (2020). Triple-Negative Breast Cancer (TNBC) Cell Metastasis is Controlled by the Opposing Actions of 5alpha-dihydroprogesterone (5alphap) and 3alpha-dihydroprogesterone (3alphahp) on Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases. https:\/\/doi.org\/10.21203\/rs.3.rs-76129\/v1.","DOI":"10.21203\/rs.3.rs-76129\/v1"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106900_bib36","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.32604\/or.2024.049918","article-title":"Aldo-keto reductases: Role in cancer development and theranostics","volume":"32","author":"Nagini","year":"2024","journal-title":"Oncol. Res"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106900_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mcp.2005.03.003","article-title":"Localization and altered expression of AKR1C family members in human ovarian tissues","volume":"19","author":"Ji","year":"2005","journal-title":"Mol. Cell Probes"},{"issue":"1-3","key":"10.1016\/j.jsbmb.2025.106900_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cbi.2011.01.003","article-title":"Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis","volume":"191","author":"Hevir","year":"2011","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106900_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cbi.2014.11.009","article-title":"Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2\u03b1 biosynthesis and action in ovarian endometriosis tissue and in model cell lines","volume":"234","author":"Sinreih","year":"2015","journal-title":"Chem. Biol. Inter."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106900_bib40","first-page":"936","article-title":"The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion","volume":"60","author":"Wiebe","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106900_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3422","article-title":"Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors","volume":"15","author":"Wiebe","year":"2013","journal-title":"Breast Cancer Res"},{"issue":"Pt A","key":"10.1016\/j.jsbmb.2025.106900_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jsbmb.2015.10.021","article-title":"Mechanism of action of the breast cancer-promoter hormone, 5\u03b1-dihydroprogesterone (5\u03b1P), involves plasma membrane-associated receptors and MAPK activation","volume":"155","author":"Wiebe","year":"2016","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"4\u20135","key":"10.1016\/j.jsbmb.2025.106900_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jsbmb.2009.11.005","article-title":"Opposing actions of the progesterone metabolites, 5\u03b1P and 3\u03b1HP, on viability of human breast cancer cells: Apoptosis, necrosis, mitosis, and cell-cell adhesion","volume":"118","author":"Wiebe","year":"2010","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106900_bib44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jsbmb.2005.05.014","volume":"97","author":"Pawlak","year":"2005","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106900_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105492","volume":"196","author":"Pelegrina","year":"2020","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106900_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3892\/ol.2023.13809","article-title":"Progesterone and its metabolite allopregnanolone promote invasion of human glioblastoma cells through metalloproteinase-9 and cSrc kinase","volume":"25","author":"Bello-Alvarez","year":"2023","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106900_bib47","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.3390\/ijms23094996","article-title":"Allopregnanolone promotes migration and invasion of human glioblastoma cells through the protein tyrosine kinase c-Src activation","volume":"23","author":"Zamora-S\u00e1nchez","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2025.106900_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.steroids.2017.01.004","article-title":"Allopregnanolone promotes proliferation and differential gene expression in human glioblastoma cells","volume":"119","author":"Zamora-S\u00e1nchez","year":"2017","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106900_bib49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.maturitas.2008.12.009","article-title":"The dialectic role of progesterone","volume":"62","author":"Huber","year":"2009","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0029-1242991","article-title":"Estrogen receptor-\u03b2, estrogen receptor-\u03b1, and progesterone resistance in endometriosis","volume":"28","author":"Bulun","year":"2010","journal-title":"Semin. Reprod. Med."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106900_bib51","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JOE-20-0106","article-title":"Androgens, oestrogens and endometrium: a fine balance between perfection and pathology","volume":"246","author":"Gibson","year":"2020","journal-title":"J. Endocrinol."},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106900_bib52","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.3390\/jcm9124105","article-title":"AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas","volume":"9","author":"Hojnik","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.jsbmb.2025.106900_bib53","unstructured":"Bairoch A. IGROV1 (Cellosaurus CVCL_1304) [Internet]. Cellosaurus; 2025 [cited 2025 Oct 8]. Available from: \u3008https:\/\/www.cellosaurus.org\/CVCL_1304\u3009."},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106900_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes","volume":"9","author":"Beaufort","year":"2014","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106900_bib55","first-page":"4970","article-title":"Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice","volume":"45","author":"B\u00e9nard","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.jsbmb.2025.106900_bib56","unstructured":"Bairoch A. SK-OV-3 (Cellosaurus CVCL_0532) [Internet]. Cellosaurus; 2025 [cited 2025 Oct 8]. Available from: \u3008https:\/\/www.cellosaurus.org\/CVCL_0532\u3009."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13073-021-00952-5","article-title":"Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes","volume":"13","author":"Barnes","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.jsbmb.2025.106900_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1104514","article-title":"Investigating the suitability of in vitro cell lines as models for the major subtypes of epithelial ovarian cancer","volume":"11","author":"McCabe","year":"2023","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.jsbmb.2025.106900_bib59","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.jsbmb.2025.106900_bib60","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.3390\/cancers17213509","article-title":"Subtype Characterization of Ovarian Cancer Cell Lines Using Machine Learning and Network Analysis: A Pilot Study","volume":"17","author":"Thelagathoti","year":"2025","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106900_bib61","article-title":"A pan-cancer survey of cell line\u2013tumor similarity by feature-weighted molecular profiles","volume":"1","author":"Sinha","year":"2021","journal-title":"Cell Rep. Methods"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106900_bib62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10585-015-9694-5","article-title":"HER2 and \u03b2-catenin protein location: importance in the prognosis of breast cancer patients and their correlation when breast cancer cells suffer stressful situations","volume":"32","author":"Cuello-Carri\u00f3n","year":"2015","journal-title":"Clin. Exp. Metastas.."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106900_bib63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10875-012-9804-y","article-title":"Immunoglobulin G from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptors","volume":"33","author":"Pelegrina","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106900_bib64","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib65","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s12885-017-3467-2","article-title":"MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer","volume":"17","author":"Swiatly","year":"2017","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106900_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12032-023-02044-3","article-title":"Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review","volume":"40","author":"Anbarasu","year":"2023","journal-title":"Med Oncol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib67","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s42003-022-03554-y","article-title":"Considering hormone-sensitive cancers as a single disease in the UK Biobank reveals shared aetiology","volume":"5","author":"Ahmed","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2025.106900_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jsbmb.2009.11.005","article-title":"Opposing actions of the progesterone metabolites, 5alpha-dihydroprogesterone (5alphaP) and 3alpha-dihydroprogesterone (3alphaHP) on mitosis, apoptosis, and expression of Bcl-2, Bax and p21 in human breast cell lines","volume":"118","author":"Wiebe","year":"2010","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106900_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-385493-3.00004-8","article-title":"Apoptosis and beyond: cytometry in studies of programmed cell death","volume":"103","author":"Wlodkowic","year":"2011","journal-title":"Methods Cell Biol."},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106900_bib71","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00424-024-02948-7","article-title":"Phosphatidylserine externalization as immune checkpoint in cancer","volume":"476","author":"Kur","year":"2024","journal-title":"Pflug. Arch."},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106900_bib72","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1039\/C5IB00109A","article-title":"Apoptosis progression studied using parallel dielectrophoresis electrophysiological analysis and flow cytometry","volume":"7","author":"Mulhall","year":"2015","journal-title":"Integr. Biol. (Camb. )"},{"key":"10.1016\/j.jsbmb.2025.106900_bib73","doi-asserted-by":"crossref","DOI":"10.1097\/CEJ.0000000000000162","article-title":"Finasteride for postmenopausal breast cancer prevention","author":"Lehrer","year":"2015","journal-title":"Eur. J. Cancer Prev."},{"issue":"1-3","key":"10.1016\/j.jsbmb.2025.106900_bib74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cbi.2011.01.003","article-title":"Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis","volume":"191","author":"Hevir","year":"2011","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.jsbmb.2025.106900_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fphar.2012.00034","article-title":"Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases","volume":"3","author":"Ri\u017ener","year":"2012","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib76","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41598-022-05785-9","article-title":"AKR1C1\/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin","volume":"12","author":"Badmann","year":"2022","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106900_bib77","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1055\/s-0032-1314834","article-title":"Allopregnanolone alters the luteinizing hormone, prolactin, and progesterone serum levels interfering with the regression and apoptosis in rat corpus luteum","volume":"44","author":"Laconi","year":"2012","journal-title":"Horm. Metab. Res"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12958-018-0353-y","article-title":"Allopregnanolone alters follicular and luteal dynamics during the estrous cycle","volume":"16","author":"Asensio","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib79","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1038\/s41598-024-57102-1","article-title":"Local effect of allopregnanolone in rat ovarian steroidogenesis, follicular and corpora lutea development","volume":"14","author":"C\u00e1ceres","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106900_bib80","article-title":"The role of non-genomic actions of progesterone and its membrane receptor agonist in ovarian cancer cell death","volume":"7","author":"Koyanagi","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106900_bib81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/humupd\/dmu056","article-title":"Role of nuclear progesterone receptor isoforms in uterine pathophysiology","volume":"21","author":"Patel","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jsbmb.2025.106900_bib82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12672-010-0023-9","article-title":"Expression of Membrane Progesterone Receptors (mPR\/PAQR) in Ovarian Cancer Cells: Implications for Progesterone-Induced Signaling Events","volume":"1","author":"Charles","year":"2010","journal-title":"HORM CANC"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106900_bib83","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.21037\/gs-20-325","article-title":"Secondary and tertiary ovarian cancer recurrence: what is the best management?","volume":"9","author":"Garzon","year":"2020","journal-title":"Gland Surg."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025002286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025002286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:40:34Z","timestamp":1776508834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076025002286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":83,"alternative-id":["S0960076025002286"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106900","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Context-dependent effects of progesterone 4-pregnene metabolites on apoptosis and proliferation in ovarian cancer cell lines IGROV-1 and SK-OV-3","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106900"}}